TARDBP and amyotrophic lateral sclerosis: A study by Liachko et al. (2013) found that inhibiting the kinase CDC7 in transgenic Caenorhabditis elegans ALS models and human cell cultures could reduce TDP-43 phosphorylation, improve behavioral phenotypes, and reduce neurotoxicity.